The fresh funds will be used to scale and develop its AI agent workforce across global life sciences enterprises, build its engineering team, and integrate with some legacy platforms within the life sciences segment. The Boston-based startup uses AI agents to automate and raise the level of efficiency of scientific knowledge work within highly regulated industries.